Medindia

X

New Four- in- one Vaccine For DTP & Hepatitis To Hit The Indian Market

by Medindia Content Team on  August 20, 2005 at 2:34 PM General Health News   - G J E 4
New Four- in- one Vaccine For DTP & Hepatitis To Hit The Indian Market
Shantetra, the first indigenously developed combination vaccine for diphtheria, tetanus, pertussis and hepatitis-B has been launched to protect children against the four life threatening diseases.
Advertisement

Shantha Biotechnics Limited, a pioneer in health care industry has manufactured and marketed the product keeping in line with the worldwide trend of switching to combination vaccines.

Advertisement
The new combination vaccine serves to fulfill a part the universal immunisation schedule against DTP and Hepatitis B and saves repeated vaccination in children, thereby reducing the associated pain.

A child should get three doses each of the two vaccines before he reaches the age of 18 months. The combination vaccine would be supplied for less than Rs.100 to doctors.

Globally 130 million children are born every year and over 30 million of them do not receive any immunisation against basic childhood infections. Three million of these children die at an early age. The main targets for the vaccine would be India and supra-national customers like UNICEF and WHO.

Source: Indo-Asian News Service
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All